Comparison of parametric imaging and SUV imaging with [68 Ga]Ga-PSMA-11 using dynamic total-body PET/CT in prostate cancer

被引:0
作者
Ruohua Chen
Yee Ling Ng
Xinlan Yang
Yinjie Zhu
Lianghua Li
Haitao Zhao
Yun Zhou
Gang Huang
Jianjun Liu
机构
[1] Shanghai Jiao Tong University,Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine
[2] Shanghai Jiao Tong University,Institute of Clinical Nuclear Medicine, School of Medicine
[3] Shanghai University of Medicine and Health Sciences,Shanghai Key Laboratory of Molecular Imaging
[4] United Imaging Healthcare Group Co.,Central Research Institute
[5] Ltd,Department of Urology, Ren Ji Hospital, School of Medicine
[6] Shanghai Jiao Tong University,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2024年 / 51卷
关键词
Prostate cancer; PSMA; Total-body dynamic PET; Parametric imaging; Kinetic modeling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:568 / 580
页数:12
相关论文
共 164 条
[1]  
Adams MC(2010)A systematic review of the factors affecting accuracy of SUV measurements AJR Am J Roentgenol 195 310-320
[2]  
Turkington TG(2014)Deriving physiological information from PET images: from SUV to compartmental modelling Clin Translat Imaging 2 239-251
[3]  
Wilson JM(2021)Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives Eur J Nucl Med Mol Imaging 48 21-39
[4]  
Wong TZ(2020)PET Parametric Imaging: Past, Present, and Future IEEE Transact Radiat Plasma Med Sci 4 663-675
[5]  
Bertoldo A(2019)Dynamic whole-body PET imaging: principles, potentials and applications Eur J Nucl Med Mol Imaging 46 501-518
[6]  
Rizzo G(2020)Subsecond total-body imaging using ultrasensitive positron emission tomography Proc Natl Acad Sci U S A 117 2265-2267
[7]  
Veronese M(2020)Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER J Nucl Med 61 285-291
[8]  
Dimitrakopoulou-Strauss A(2020)The image quality, lesion detectability, and acquisition time of (18)F-FDG total-body PET/CT in oncological patients Eur J Nucl Med Mol Imaging 47 2507-2515
[9]  
Pan L(2022)Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT Eur J Nucl Med Mol Imaging 49 2086-2095
[10]  
Sachpekidis C(2022)The Added Value of (18)F-FDG PET/CT Compared with (68)Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer J Nucl Med 63 69-75